Methods & Compositions for the Activation of Gamma-delta T-cells
Country:
US
Docket No:
436313-003100
Publication Number:
10,137,144
Patent Expiry:
01/13/2037
Claims Scope:
Patent issued November 27, 2018.
80% Sequence Identity – Compositions & Methods
Composition & Methods of treating cancer with a bisphosphonate drug in combination with a lentiviral particle comprising shRNA having at least 80% percent identity to SEQ 1-4, or, microRNA having at least at least 80% identity to SEQ 5-10.
